10x Genomics, Inc. — Director's Dealing 2020

Dec 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2020-12-24

Reporting Person: Hindson Benjamin J. (Director, See Remarks, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-24	Class A Common Stock	M	8636	$0.88	Acquired	76136	Direct
2020-12-24	Class A Common Stock	M	28000	$1.20	Acquired	104136	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-24	Stock Option (right to buy)	$0.88	M	8636	Disposed	2025-10-27	Class A Common Stock (8636)	Direct
2020-12-24	Stock Option (right to buy)	$1.20	M	28000	Disposed	2027-10-18	Class A Common Stock (28000)	Direct

Footnotes

F1: All of the shares subject to the option are fully vested and exercisable as of the date hereof.

F2: This option, originally for 200,000 shares, of which 28,000 shares have been exercised, vested as to one forty-eighth of the shares on October 1, 2017 and one forty-eighth of the shares subject to the option vest each month thereafter, subject to the Reporting Person continuing as a service provider through each such date.